LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 48.65 | 84.90 | 452 | 5328 | 0.0848 | 0.3232 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 48.65 | 84.90 | 5443 | 5328 | 1.0214 | 1.0071 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.36 | 84.90 | 5528 | 5651 | 0.9782 | 0.9927 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.36 | 84.90 | 5628 | 5651 | 0.9959 | 0.9987 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.36 | 84.90 | 568 | 5651 | 0.1005 | 0.3686 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.36 | 84.90 | 5813 | 5651 | 1.0287 | 1.0093 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.06 | 84.90 | 5748 | 5990 | 0.9595 | 0.9866 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.06 | 84.90 | 5866 | 5990 | 0.9792 | 0.9932 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.06 | 84.90 | 606 | 5990 | 0.1012 | 0.3772 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.06 | 84.90 | 6134 | 5990 | 1.0239 | 1.0077 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.77 | 84.90 | 6052 | 6252 | 0.9679 | 0.9895 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.77 | 84.90 | 6164 | 6252 | 0.9858 | 0.9954 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.77 | 84.90 | 704 | 6252 | 0.1126 | 0.4064 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.77 | 84.90 | 6443 | 6252 | 1.0304 | 1.0097 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.48 | 84.90 | 6348 | 6567 | 0.9665 | 0.9892 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.48 | 84.90 | 6487 | 6567 | 0.9877 | 0.9961 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.48 | 84.90 | 706 | 6567 | 0.1075 | 0.4016 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.48 | 84.90 | 6831 | 6567 | 1.0401 | 1.0126 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 57.18 | 84.90 | 6635 | 6963 | 0.9528 | 0.9849 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 57.18 | 84.90 | 6775 | 6963 | 0.9730 | 0.9914 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 57.18 | 84.90 | 810 | 6963 | 0.1163 | 0.4259 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 57.18 | 84.90 | 7217 | 6963 | 1.0364 | 1.0113 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.88 | 84.90 | 6914 | 7291 | 0.9482 | 0.9835 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.88 | 84.90 | 7068 | 7291 | 0.9693 | 0.9903 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.88 | 84.90 | 753 | 7291 | 0.1033 | 0.4046 | MN20160318_Q02 | K13 |